NAD+ (Nicotinamide Adenine Dinucleotide) | Compounded Injectable
Important Safety Information: NAD+ (Nicotinamide Adenine Dinucleotide) | Compounded Injectable
What is this?
This Important Safety Information summarizes key warnings and precautions for Nicotinamide Adenine Dinucleotide (NAD+), a coenzyme found naturally in all living cells. NAD+ plays a central role in cellular energy production, mitochondrial function, redox reactions, DNA repair, and cellular signaling. NAD+ levels naturally decline with age and during certain metabolic conditions. This compounded injectable formulation is not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy and should only be used exactly as directed by a licensed healthcare provider. This summary does not include all available information. Always read your medication label and follow your provider’s instructions.
Most Serious Warnings
Product can cause:
Severe allergic reactions, including rash, hives, swelling of the face, lips, tongue, or throat, and difficulty breathing
Shortness of breath, chest tightness, or respiratory discomfort, particularly with rapid infusion
Headache, especially if administered too quickly
Changes in liver function laboratory values
Fluid or metabolic shifts that may require monitoring in certain individuals
Compounded NAD+ injections may carry sterility or formulation risks due to limited FDA oversight.
Who Should NOT Take NAD+
Do not take this medication if you:
Have a known allergy to NAD+ or any ingredient in the formulation
Have experienced a prior hypersensitivity reaction to NAD+ infusion
Have been advised by your provider to avoid intravenous or injectable therapies
Are pregnant or breastfeeding without explicit provider guidance
Before Taking NAD+, Tell Your Healthcare Provider if You:
Have liver disease or abnormal liver function tests
Have kidney disease or metabolic disorders
Have heart or lung conditions
Have a history of substance use disorder and are pursuing treatment
Are taking prescription, over the counter, or herbal medications
Have a history of allergic reactions to injectable products
Are pregnant, planning pregnancy, or breastfeeding
Possible Side Effects
Common (mild to moderate):
Headache
Shortness of breath during infusion
Nausea
Constipation
Injection site discomfort
Temporary changes in liver enzymes or bilirubin on laboratory testing
Serious (seek medical care immediately):
Swelling of the face, lips, tongue, or throat
Difficulty breathing or wheezing
Severe or persistent chest discomfort
Severe headache or neurological changes
Signs of a severe allergic reaction
While Taking NAD+
Tell your healthcare provider immediately if you:
Experience worsening shortness of breath during or after infusion
Develop severe headache or visual disturbances
Notice yellowing of the skin or eyes
Experience persistent abdominal discomfort
Develop any unusual or concerning symptoms
Infusion rate may affect tolerability. Rapid administration has been associated with increased headache and shortness of breath in some reports. Your provider may adjust dosing or infusion speed based on your response.
Pregnancy and Fertility
There are limited clinical data regarding the use of injectable NAD+ during pregnancy or breastfeeding. Use during pregnancy or lactation should occur only if clearly recommended and supervised by a licensed healthcare provider.
Overdose
Symptoms of NAD+ overdose may include:
Severe headache
Significant shortness of breath
Nausea or vomiting
Abnormal laboratory values
Generalized discomfort
If overdose is suspected, seek emergency medical attention or contact Poison Control right away.
Missed Dosage
If you miss a scheduled dose:
Do not double the next dose
Contact your provider for guidance on rescheduling
Follow your provider’s instructions for ongoing therapy
Storage
Store as directed on the pharmacy label
Protect from excessive heat and light
Do not freeze
Keep out of reach of children and pets
Follow beyond use dating provided on your prescription label
Medication Disposal
Dispose of unused or expired medication according to local medication disposal guidelines. Do not dispose of injectable medication in household trash without proper precautions. Contact your pharmacy or healthcare provider for appropriate disposal instructions.
Provider Oversight and Order Review
This compounded medication requires review and oversight by licensed Superior Health and Wellness providers. Dosing schedules, infusion protocols, and monitoring plans must be discussed directly with your provider to ensure safety and clinical appropriateness. Orders may be adjusted based on laboratory findings, treatment goals, and individual response.
Telemedicine Disclosure
This prescription may be issued via telemedicine. If you experience concerning or severe symptoms, contact your prescribing clinician immediately or seek emergency medical care.
Disclaimer
This summary does not include all information about NAD+ injection and should not replace medical guidance. Always consult your healthcare provider or pharmacist for complete safety information, potential interactions, and individualized treatment recommendations. This compounded medication has not been evaluated or approved by the FDA for safety or efficacy. You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit MedWatch or call 1-800-FDA-1088.
